Trials / Completed
CompletedNCT00090584
Behavior Enhances Drug Reduction of Incontinence (BE-DRI)
Behavior Enhances Drug Reduction of Incontinence
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 307 (actual)
- Sponsor
- Carelon Research · Academic / Other
- Sex
- Female
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
The primary aim of this study is to test if the addition of behavioral treatment to drug therapy for the treatment of urge incontinence will increase the number of patients who can discontinue drug therapy and sustain a significant reduction of incontinence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tolterodine | 4mg/d for 10 weeks. Could be reduced to 2mg/d for managing side effects. |
| BEHAVIORAL | Behavioral training | Training in pelvic floor muscle control and exercises; behavioral strategies to diminish urgency, suppress bladder contractions and prevent incontinence; delayed voiding; and individualized fluid management. |
Timeline
- Start date
- 2004-08-01
- Primary completion
- 2005-12-01
- Completion
- 2006-08-01
- First posted
- 2004-08-31
- Last updated
- 2013-06-17
- Results posted
- 2013-06-17
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00090584. Inclusion in this directory is not an endorsement.